Conferences - Results from #8640

Viewing 8641-8660 of 11724 articles

IBCN 2017: Urologist-Led Success Stories in Stewardship of Imaging for Bladder Cancer

AUA QI Summit 2017: Urologist-Led Success Stories in Stewardship of Imaging for Prostate Cancer

AUA QI Summit 2017: Potentially Avoidable Harms from Radiation: Keynote Address

AUA QI Summit 2017: Need for Physician-Led Stewardship of Imaging in Urology

AUA QI Summit 2017: National Quality Initiatives in Renal Colic Imaging from the American College of Emergency Physicians (ACEP)

AUA QI Summit 2017: Optimizing Implementation of Prostate MRI

SIU 2017: ProtecT, PIVOT and SPCG-4: Placing New Evidence into Context

SIU 2017: Evidence-Based Outcomes in Oncology: Implications for Patient Care

SIU 2017: American Urological Association Lecture - Adrenal Imaging: A Urologist’s Perspective

SIU 2017: Translational Observations from Mutation Profiling of Muscle Invasive Bladder Cancer

SIU 2017: ProtecT in 2017: What Have We Learnt?

SIU 2017: MRI As a Triage Test in Prostate Cancer Diagnostic Algorithm in Biopsy - Naïve Men: A Prospective Study

SIU 2017: Economic Effectiveness of Urinary PCA3 Test in Cases of Serum PSA Level 4-10 Ng/Ml

SIU 2017: Neoadjuvant Chemo - When, What and Why?

SIU 2017: Can Genetic Analysis in Bladder Cancer Enhance Decision Making

SIU 2017: Atypical Small Acinar Proliferation: Progression to Clinically Significant Prostate Cancer?

SIU 2017: Biojet – Real Time TRUS/MRI Fusion Biopsy of The Prostate: Value of Combining Targeted and Systematic Biopsies

SIU 2017: Transperineal Template-Guided Mapping Biopsy and Multiparametric MRI for Detection of Clinically Significant Prostate Cancer in Patients after initial Negative Trans-rectal Ultrasound-Guided Biopsy

SIU 2017: Combined Clinical Parameters and Multiparametric MRI for Advanced Risk Modeling of Prostate Cancer - Patient-Tailored Risk Stratification Can Reduce Unnecessary Biopsies

SIU 2017: Correlation of mpMRI Contours with 3-Dimensional 5mm Transperineal Prostate Mapping Biopsy within the PROMIS Trial Pilot: What Margins Are Required?

428
429
430
431
432
433
434
435
436
437